Enzene Biosciences launches Cetuximab, biosimilar of cancer drug Erbitux
Cetuximab is a therapeutic chimeric monoclonal antibody that is used as a targeted therapy for metastatic colorectal cancer (mCRC)…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.